Frontiers in Pharmacology article

We encourage you to read the publication available in Frontiers in Pharmacology, co-authored by Robert Plisko, president of HTA Consulting: “The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures”.

Full text of the publication available here.